Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10448620 | 0.78 | MEN1 (0.38) | ALDH1A1MEN1KMT2APOLBCYP2C19 | |
| SCHEMBL1580250 | 0.75 | MEN1 (0.33) | ALDH1A1MEN1KMT2APOLB | |
| SCHEMBL9541497 | 0.75 | — | — | |
| SCHEMBL2361514 | 0.74 | MEN1 (0.31) | ALDH1A1MEN1KMT2APOLB | |
| SCHEMBL9058786 | 0.73 | POLB (0.36) | ALDH1A1MEN1KMT2APOLB | |
| SCHEMBL1176321 | 0.73 | ALDH1A1 (0.34) | ALDH1A1MEN1KMT2APOLBTSHR | |
| SCHEMBL9860889 | 0.73 | MEN1 (0.34) | ALDH1A1MEN1KMT2APOLB | |
| SCHEMBL9500358 | 0.73 | MEN1 (0.34) | ALDH1A1MEN1KMT2APOLB | |
| SCHEMBL8102301 | 0.73 | MEN1 (0.34) | ALDH1A1MEN1KMT2APOLB | |
| SCHEMBL164257 | 0.73 | MEN1 (0.40) | ALDH1A1MEN1KMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 206 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2662434-B2 | Use of specific compounds for enhancing odours | SYMRISE AG (DE) | 2023-08-16 | — | — | EP | claimed |
| EP-3884018-A1 | JASMOL | Symrise AG (DE) | 2021-09-29 | — | — | EP | claimed |
| US-10876081-B2 | Method for the production of scent capsules with improved surfactant stability | SYMRISE AG (DE) | 2020-12-29 | — | — | US | claimed |
| EP-3423028-B1 | METHOD FOR THE PRODUCTION OF ENCAPSULATED FRAGRANCE WITH IMPROVED STABILITY AGAINST DETERGENTS | SYMRISE AG (DE) | 2020-04-08 | — | — | EP | claimed |
| EP-3601509-A1 | FRAGRANCE MIXTURES CONTAINING TRICYCLO[5.2.1.0]-DECANE-8-ETHYL ETHER | Symrise AG (DE) | 2020-02-05 | — | — | EP | claimed |
| EP-2662434-B1 | Use of specific compounds for enhancing odours | SYMRISE AG (DE) | 2018-03-21 | — | — | EP | claimed |
| US-8999913-B2 | Fragrance mixtures containing cyclopent-2-enyl ethyl acetate | SYMRISE AG (DE) | 2015-04-07 | — | — | US | claimed |
| US-20130172429-A1 | FRAGRANCE MIXTURES CONTAINING CYCLOPENT-2-ENYL ETHYL ACETATE | SYMRISE AG (DE) | 2013-07-04 | — | — | US | claimed |
| WO-2011147455-A1 | FLAVORING SUBSTANCE-INCLUDED COMPOUNDS | SYMRISE AG (DE) | 2011-12-01 | — | — | WO | claimed |
| EP-1385470-B1 | FRAGRANT MIXTURES WITH INCREASED STRENGTH OF ODOR | SYMRISE GMBH & CO KG (DE) | 2007-08-08 | — | — | EP | claimed |
| US-12630783-B2 | Muguet type fragrance compounds | SYMRISE AG (DE) | 2026-05-19 | — | — | US | disclosed |
| US-12577495-B2 | Fragrance mixtures containing 1-(4,4-dimethylcyclohexen-1-yl) ethanon | SYMRISE AG (DE) | 2026-03-17 | — | — | US | disclosed |
| EP-4687810-A1 | PREPARATIONS COMPRISING HYDROXY PINACOLONE RETINOATE | Symrise AG (DE) | 2026-02-11 | — | — | EP | disclosed |
| US-12545851-B2 | Fragrances with note of lily of the valley | SYMRISE AG (DE) | 2026-02-10 | — | — | US | disclosed |
| EP-3684898-B1 | METHOD FOR PRODUCING AN ACTIVE SUBSTANCE WAFER | SYMRISE AG (DE) | 2025-04-30 | — | — | EP | disclosed |
| US-7348035-B2 | Cyclodextrin particle | SYMRISE GMBH & CO. KG (DE) | 2008-03-25 | — | — | US | disclosed |
| US-20070298994-A1 | Use of 3-Mercapto-3-Methyl-Hexan-1-Ol for Use as Malodour Standard | SYMRISE GMBH & CO. KG (DE) | 2007-12-27 | — | — | US | disclosed |
| US-20070191258-A1 | 3-Methylbenzyl-isobutyrate | SYMRISE GMBH & CO. KG (DE) | 2007-08-16 | — | — | US | disclosed |
| US-20040234479-A1 | Cyclodextrin particle | SYMRISE GMBH & CO. KG (DE) | 2004-11-25 | — | — | US | disclosed |
| US-20020192174-A1 | Perfume mixtures with increased odor intensity | SYMRISE GMBH & CO. KG (DE) | 2002-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577495-B2 | Fragrance mixtures containing 1-(4,4-dimethylcyclohexen-1-yl) ethanon | ALG3, FAAH, FAAH2 | ALDH1A1 53/4885MEN1 1902/4885KMT2A 1191/4885 |
| US-12630783-B2 | Muguet type fragrance compounds | MGAT1, RFT1, CPT1A | ALDH1A1 132/4885MEN1 1286/4885KMT2A 339/4885 |
| US-12545851-B2 | Fragrances with note of lily of the valley | TRPA1, CDY1; CDY1B, TMEM109 | ALDH1A1 74/4885MEN1 3646/4885KMT2A 1252/4885 |
| US-10876081-B2 | Method for the production of scent capsules with improved surfactant stability | SMOX, LIPA, SGMS2 | ALDH1A1 804/4885MEN1 1928/4885KMT2A 1413/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.